Auauniversity

Take Home Messages from AUA2018 in Pediatrics presented by Emilie Johnson, MD, MPH. In addition Plenary Next Frontier presentations in the area of pediatric urology Highlights: Society for Pediatric Urology presented by Caleb Nelson, MD, MPH Journal of Urology Highlights: Pediatrics presented by Julian Wan, MD

This podcast was developed from content delivered during the Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer live course. Topics covered include: Practical Guide to an Advanced Prostate Cancer Clinic, Presented by Lawrence I. Karsh, MD, FACS Biomarkers for Advanced Prostae Cancer: Ready for Prime Time?, Presented by Daniel W. Lin, MD Acute and Chronic Pain Management in CRPC, Presented by Russell Z. Szmulewitz, MD End-of-Life Issues in CRPC Patients and their Families, Presented by Russell Z. Smulewitz, MD CME Available: https://auau.auanet.org/node/21876

Immuno-Oncology: A Focus on Prostate Cancer is the fourth webcast in the 4-part series. Topics will include "review of treatment options for advanced disease", "evolution of AR-directed treatment and chemotherapy" as well as "impact of immunotherapy on treatment of advanced disease". CME Available: https://auau.auanet.org/node/21419

AUA2018 Residents Forum - The Evolving Practice Of Urology by AUAUniversity

AUA2018 Residents Forum - Wellness Burnout And Sustaining Your Career by AUAUniversity

Immuno-Oncology: A Focus on Kidney Cancer is the third in the 4-part series. Topics will include "Review of Treatment Options for Systemic Disease", "Cytoeduction Debate" and "Impact of Immunotherapy on Treatment". CME Available: https://auau.auanet.org/node/21355

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer: Present and Future is the fourth and final in a 4-part series. Topics will include "Role of Chemotherapy and Performance Status and Pain Management" and "Treatment Sequencing, Immunotherapy and Future Approaches". CME Available: https://auau.auanet.org/node/19911

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of adverse events, the AUA is producing a series of online activities for clinicians and other healthcare professionals. The 2018 series is comprised of a variety of activities, including four live webinars, webcasts and podcasts plus three podcast addressing the barriers to immunotherapy treatment of GU cancer. All activities are complimentary. Breaking Down the Barriers: Incorporating New IO Therapies Podcast Series - How to Properly Administer IO Therapies in an Infustion Suite is the third podcast in a 3-part series. CME Available: https://auau.auanet.org/node/20964

Immuno-Oncology: A Focus on Bladder Cancer is the second in the 4-part series. Topics will include "non muscle invasive disease" and "muscle invasive disease" as well as "clinical trial evidence" and "future directions and biomarkers" of both. CME Available: https://auau.auanet.org/node/21348

Speakers: Christopher M. Gonzalez, MD, MBA James M. Dupree, MD, MPH

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of adverse events, the AUA is producing a series of online activities for clinicians and other healthcare professionals. The 2018 series is comprised of a variety of activities, including four live webinars, webcasts and podcasts plus three podcast addressing the barriers to immunotherapy treatment of GU cancer. All activities are complimentary. Breaking Down the Barriers: Incorporating New IO Therapies Podcast Series - Managing Patient Side Effects is the second podcast in a 3-part series. CME Available: https://auau.auanet.org/node/20963

Immuno-Oncology: A New Class of Drugs is the first in the 4-part series. Topics will include "Tumor Immunotherapy", "Immunotherapy Drug Availability and Mechanisms of Action", "Vaccines", "Monoclonal Antibodies" and "Checkpoint Inhibitors". CME Available: https://auau.auanet.org/node/21336

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer: What's New is the third podcast in a 4-part series. Topics will include "Manipulating the Androgen Axis: Androgen Biosynthesis Inhibitors and Androgen Receptor Signaling Agents" and "Radionuclide Therapy and Bone Health". CME Available: auau.auanet.org/node/19909 Release date:

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of adverse events, the AUA is producing a series of online activities for clinicians and other healthcare professionals. The 2018 series is comprised of a variety of activities, including four live webinars, webcasts and podcasts plus three podcast addressing the barriers to immunotherapy treatment of GU cancer. All activities are complimentary. Breaking Down the Barriers: Incorporating New IO Therapies Podcast Series - Biomarkers is the first podcast in a 3-part series. CME Available: https://auau.auanet.org/node/20962

To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation are producing a series of online activities and educational resources for healthcare professionals, patients and caregivers. One of those such activities is this complimentary AUA Castration-Resistant Prostate Cancer Guideline Amendment webinar. This 60-minute, knowledge-based, live webinar is offered at two different dates and times for the learner's convenience.. The goal of this complimentary webinar is to improve clinicians’ understanding of the 2018 update to the 2013 AUA Guidelines on CRPC. During this webinar, expert Faculty will: Explore the rigorous process used in the development of these evidence-based guidelines. Discuss new developments and future research needs for this topic. Showcase clinical scenarios in urological practice and the correct application of the new AUA guidelines in those instances. CME Available: ht

Take Home Messages from AUA2018 Infertility / Andrology Lawrence Jenkins, MD, MBA The Ohio State University Sexual Dysfunction Nelson Bennett, Jr., MD, FACS Northwestern University Feinberg School of Medicine

Take home messages from AUA2018 Endourology/Stones: Zeph Okeke, MD Infection/Inflammation: O. Lenaine Westney, MD, FPMRS

To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation has produced a series of online activities and educational resources for healthcare professionals, patients and caregivers. One of those such activities is this complimentary Emerging Treatment Options for Non-Metastatic CRPC Podcast (2018). https://auau.auanet.org/node/20087

In a webinar on Feb. 26, moderator Seth Cohen, MD, and panelists Gina Badaloto, MD, Moben Mirza, MD, Jessica Kreshover, MD, and Taylor Kohn (MS4) provide an overview on the application cycle to the Urology Match Program and offer advice for urology candidates seeking to maximize their efforts during this process. They also answer questions about the process for selecting away rotations and offer insight into the various aspects of different training experiences.

Emerging Treatment of M0 CRPC: Update on the AUA/SUO Guidelines is the second podcast in a 4-part series. Topics will include “M0 CRPC: Emerging Treatment Options” and “MDC and Review of CRPC Guidelines”. CME Available: auau.auanet.org/node/19907